The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Biologic Therapeutic Drugs: Technologies and Global Markets
US$ 4,650.00
Report This report provides an overview of the global biologic therapeutic drug market and analyzes market trends. It includes global revenue ($U.S. millions) for base year data for 2023 and estimated...
May 2025
170 pages
Hemorrhoid Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Over-the-counter (OTC) Products, Prescription Medications, Medical Devices, Surgical Products and Other Product Types), Treatment Type (Pharmacological Treatments, Minimally Invasive Procedures and Surgical Treatments), Disease Type, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Hemorrhoid Treatment Market is accounted for $1.20 billion in 2025 and is expected to reach $2.07 billion by 2032 growing at a CAGR of 8.10% during the forecas...
May 2025
150 pages
Strep Throat Treatment Market Forecasts to 2032 – Global Analysis By Treatment Type (Antibiotics, Pain Relievers, Probiotic Therapies, Herbal/Natural Remedies and Other Treatment Types), Route of Administration (Oral, Topical and Injectable), Disease Type, Distribution Channel, Diagnosis Method, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Strep Throat Treatment Market is accounted for $2.26 billion in 2025 and is expected to reach $3.88 billion by 2032 growing at a CAGR of 8.0% during the foreca...
May 2025
150 pages
Hermansky Pudlak Syndrome Market 2026
US$ 2,999.00
The Hermansky Pudlak Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
April 2025
210 pages
Europe Sickle Cell Disease Treatment Market - 2024-2033
US$ 2,999.00
The Europe Sickle Cell Disease Treatment Market was valued at US$ 883.26 million in 2024 and is anticipated to reach US$ 2,492.84 million by 2033, at a CAGR of 0.157 from 2026 to 2032. The report deli...
April 2025
243 pages
Generalized Myasthenia Gravis Treatment Market - 2024-2033
US$ 2,999.00
The Generalized Myasthenia Gravis Treatment Market was valued at US$ 3.78 billion in 2024 and is anticipated to reach US$ 15.57 billion by 2033, at a CAGR of 0.171 from 2026 to 2032. The report delive...
April 2025
220 pages
Hutchinson-Gilford Progeria Syndrome Market 2026
US$ 2,999.00
The Hutchinson-Gilford Progeria Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
April 2025
243 pages
Latin America Pain Management Drugs Market - 2024-2033
US$ 2,999.00
The Latin America Pain Management Drugs Market was valued at US$ 4,069.52 million in 2024 and is anticipated to reach US$ 6,576.78 million by 2033, at a CAGR of 0.056 from 2026 to 2032. The report del...
April 2025
218 pages
North America Pain Management Market - 2024-2033
US$ 2,999.00
The North America Pain Management Market was valued at US$ 25.85 billion in 2024 and is anticipated to reach US$ 46.87 billion by 2033, at a CAGR of 0.069 from 2026 to 2032. The report delivers in-dep...
April 2025
219 pages
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030
US$ 4,950.00
The global market for oral proteins and peptides is projected to reach USD 24.00 billion by 2030 from USD 8.85 billion in 2025, at a CAGR of 22.1% during the forecast period from 2025 to 2030. The inc...
April 2025
326 pages
Prader-Willi Syndrome Market - 2024-2033
US$ 2,999.00
The Prader-Willi Syndrome Market was valued at US$ 633.56 million in 2024 and is anticipated to reach US$ 1,078.80 million by 2033, at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth in...
April 2025
218 pages
Europe Pain Management Drugs Market - 2024-2033
US$ 2,999.00
The Europe Pain Management Drugs Market was valued at US$ 17.13 billion in 2024 and is anticipated to reach US$ 33.77 billion by 2033, at a CAGR of 0.079 from 2026 to 2032. The report delivers in-dept...
April 2025
217 pages
GM1 Gangliosidosis Treatment Market 2026
US$ 2,999.00
The GM1 Gangliosidosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
April 2025
220 pages
Compounding Chemotherapy Market By Dose type (Chemotherapeutic, Non-chemotherapeutic), By Compounding Type (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration), By Delivery method (Gravimetric automated Compounding Device, Volumetric Automated Compounding Device), By Sterility (Sterile, Non-sterile), By Technology (With Robotic arm, Without Robotic Arm): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The compounding chemotherapy market was valued at $5,267.03 million in 2024 and is estimated to reach $9,826.7 million by 2034, exhibiting a CAGR of 6.4% from 2025 to 2034.Compounding chemotherapy inv...
April 2025
364 pages
Dermatophytic Onychomycosis Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Tablets, Nail Paints/Lacquers, Ointments & Creams, Laser Therapy Devices, Photodynamic Therapy (PDT) Solutions, and Other Product Types), Route of Administration, Treatment, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dermatophytic Onychomycosis Treatment Market is accounted for $5.7 billion in 2025 and is expected to reach $10.8 billion by 2032 growing at a CAGR of 9.5% dur...
April 2025
150 pages
Gaucher Disease Pipeline Insights 2025 2026
US$ 2,999.00
The Gaucher Disease Pipeline Insights 2025 was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
March 2025
210 pages
IgA Nephropathy Drugs Market - 2022
US$ 2,999.00
The IgA Nephropathy Drugs Market was valued at US$ 120.1 million in 2022 and is anticipated to reach by , at a CAGR of 0.181 from 2026 to 2032. The report delivers in-depth insights into key market dy...
March 2025
217 pages
Hunter Syndrome Treatment Market - 2024-2033
US$ 2,999.00
The Hunter Syndrome Treatment Market was valued at US$ 747.06 million in 2024 and is anticipated to reach US$ 1,417.79million by 2033, at a CAGR of 0.075 from 2026 to 2032. The report delivers in-dept...
March 2025
223 pages
Beh?et’s Disease Market 2026
US$ 2,999.00
The Behcet’s Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
March 2025
207 pages
Global Gaucher Disease Treatment Market - 2024-2033
US$ 2,999.00
The Global Gaucher Disease Treatment Market was valued at US$ 1.76 billion in 2024 and is anticipated to reach US$ 2.28 billion by 2033, at a CAGR of 0.029 from 2026 to 2032. The report delivers in-de...
March 2025
210 pages
Hurler Syndrome Treatment Market - 2024-2033
US$ 2,999.00
The Hurler Syndrome Treatment Market was valued at US$ 377.65 million in 2024 and is anticipated to reach US$ 529.34 million by 2033, at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth...
March 2025
207 pages
Hydronephrosis Market 2026
US$ 2,999.00
The Hydronephrosis Market was valued at in and is anticipated to reach by , at a CAGR of 0.095 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
March 2025
219 pages
Alpha Thalassemia Market - 2022-2031
US$ 2,999.00
The Alpha Thalassemia Market was valued at US$ 1.1 billion in 2022 and is anticipated to reach US$ 1.9 billion by 2031, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights into...
March 2025
220 pages
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Central Nervous System Infections, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others)...
March 2025
406 pages
Albendazole Anthelmintic Drug Market 20262031
US$ 2,999.00
The Albendazole Anthelmintic Drug Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
February 2025
223 pages
Krabbe Disease Treatment Market 2026
US$ 2,999.00
The Krabbe Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.0786 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
February 2025
223 pages
Hypovolemic Shock Market 2026
US$ 2,999.00
The Hypovolemic Shock Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
February 2025
207 pages
Hypereosinophilic Syndrome Market 2026
US$ 2,999.00
The Hypereosinophilic Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of 0.086 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
February 2025
217 pages
Anti-senescence Therapeutics Market - 2024-2033
US$ 2,999.00
The Anti-senescence Therapeutics Market was valued at US$ 30.96 billion in 2024 and is anticipated to reach US$ 53.39 billion by 2033, at a CAGR of 0.067 from 2026 to 2032. The report delivers in-dept...
February 2025
243 pages
Hormonal Contraceptive Market By Product (Oral contraceptive pills, Injectable birth control, Emergency contraceptive pills, Vaginal rings, Transdermal patches, IUS and Implants), By Hormone (Progestin only contraceptive, Combined hormonal contraceptive), By Age Group (15 to 24 years, 25 to 34 years, 35 to 44 years, Above 44 years), By End User (Hospitals, Household, Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
... use of contraceptives hamper the market growth. The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified ...
February 2025
348 pages
Aspirin Drugs Market By Dosage Form (Tablets, Capsules, Others), By Application (Pain Relief, Cardiovascular Disease Prevention, Anti-inflammatory Uses, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
The aspirin drugs market was valued for $1.3 billion in 2023 and is estimated to reach $1.8 billion by 2035, exhibiting a CAGR of 2.7% from 2024 to 2035. Aspirin, also known as acetylsalicylic acid, i...
February 2025
264 pages
Food Allergy Treatment Market Forecasts to 2030 – Global Analysis By Allergen Type (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Soys and Other Allergen Types), Drug Type, Route of Administration, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Food Allergy Treatment Market is accounted for $7.13 billion in 2024 and is expected to reach $12.81 billion by 2030 growing at a CAGR of 10.27% during the for...
February 2025
150 pages
Genital Dysfunction Drugs Market - 2023-2031
US$ 2,999.00
The Genital Dysfunction Drugs Market was valued at US$ 4.15 billion in 2023 and is anticipated to reach US$ 7.16 billion by 2031, at a CAGR of 0.07 from 2026 to 2032. The report delivers in-depth insi...
January 2025
223 pages
Gluten Intolerance Treatment Market - 2024-2032
US$ 2,999.00
The Gluten Intolerance Treatment Market was valued at US$ 6.63 billion in 2024 and is anticipated to reach US$ 16.18 billion by 2032, at a CAGR of 0.118 from 2026 to 2032. The report delivers in-depth...
January 2025
218 pages
Hemophilia B Market 2026
US$ 2,999.00
The Hemophilia B Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
January 2025
200 pages
